Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
NYXH
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.23
N/A
-0.49
vs -0.21
Q3.23
N/A
-0.29
vs -0.24
Q4.23
N/A
-0.41
vs -0.52
Q1.24
N/A
-0.45
vs -0.49
Q2.24
N/A
-0.46
vs -0.49
Q3.24
N/A
-0.55
vs -0.29
Q4.24
N/A
-0.49
vs -0.41
Q1.25
N/A
-0.63
vs -0.45
Q2.25
N/A
-0.57
vs -0.46
Q3.25
N/A
-0.61
vs -0.55
Sales Growth
YoY
Current
Estimates
Q2.23
+18%
1.1M vs 935K
Q3.23
+436%
976K vs 182K
Q4.23
+40%
1.8M vs 1.3M
Q1.24
+177%
1.2M vs 441K
Q2.24
-30%
771K vs 1.1M
Q3.24
+30%
1.3M vs 976K
Q4.24
-31%
1.3M vs 1.8M
Q1.25
-13%
1.1M vs 1.2M
Q2.25
+73%
1.3M vs 771K
Q3.25
+109%
2.6M vs 1.3M
Return on Equity
QoQ
Q2.23
-11%
-0.11
vs -0.10
Q3.23
-7%
-0.07
vs -0.11
Q4.23
-11%
-0.11
vs -0.07
Q1.24
-14%
-0.14
vs -0.11
Q2.24
-11%
-0.11
vs -0.14
Q3.24
-16%
-0.16
vs -0.11
Q4.24
-15%
-0.15
vs -0.16
Q1.25
-24%
-0.24
vs -0.15
Institutionnal Ownership
QoQ
Q2.23
16
16
vs 18
-11%
Q3.23
17
17
vs 16
6%
Q4.23
16
16
vs 17
-6%
Q1.24
19
19
vs 16
19%
Q2.24
20
20
vs 19
5%
Q3.24
20
20
vs 20
NA
Q4.24
22
22
vs 20
10%
Q1.25
26
26
vs 22
18%
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
NASDAQ
Unprofitable
Unprofitable
-0.16 ( -2.14%)
Relative Strenght
60
Volume Buzz
-21%
Earning Acce
No
Dist 52w H.
39%
globenewswire.com
1 hour ago
accessnewswire.com
9 hours ago
seekingalpha.com
14 hours ago
globenewswire.com
16 hours ago
globenewswire.com
16 hours ago
globenewswire.com
16 hours ago
Forecast
4451%2026-Revenue
-225%2026-EPS
-128%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
0.00(-100.00%)
Number of analyst
0
Last analyst upgrade/downgrade
No Data Available
Relative Strength
NYXH
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Quote Panel
Key Metrics